title: Cost-effectiveness analysis of pandemic influenza preparedness: what's missing?
authors.affiliation: London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, England. thomas.drake@lshtm.ac.uk
authors.forename: Tom L
authors.initials: TL
authors.lastname: Drake
authors.forename: Zaid
authors.initials: Z
authors.lastname: Chalabi
authors.forename: Richard
authors.initials: R
authors.lastname: Coker
mesh_terms: D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use; D002160:Cambodia; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000458:organization & administration*; D004189:Disaster Planning / Q000191:economics* / Q000458:organization & administration; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology*; D058873:Pandemics
chemical_list: D000998:Antiviral Agents